Study guide
Paediatric Ethics, Consent/Assent, Gillick Competence, and Patient Safety
EBP-EAP Examination in Paediatrics Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Governance, Ethics & Child Safeguarding
EBP-EAP Format, Delivery, Scoring, and Clinical Vignette Strategy Paediatric Ethics, Consent/Assent, Gillick Competence, and Patient Safety Child Protection, Physical/Emotional Abuse, Neglect, and Non-Accidental Injury (NAI)
2 Chapter 2: Neonatal Transition, Resuscitation & Prematurity
Delivery Room Care, Apgar Scoring, and Neonatal Resuscitation Algorithm Respiratory Distress Syndrome (RDS), Surfactant Therapy, and Bronchopulmonary Dysplasia Perinatal Asphyxia, HIE Sarnat Staging, and Therapeutic Hypothermia Protocol
3 Chapter 3: Neonatal Morbidities, Jaundice & Congenital Infections
Unconjugated vs Conjugated Hyperbilirubinemia, Phototherapy Thresholds, and Exchange Transfusion Early- vs Late-Onset Sepsis, Group B Streptococcus, and Congenital TORCH Infections NEC Diagnosis/Bell Staging, Neonatal Hypoglycaemia, and Newborn Bloodspot Screening
4 Chapter 4: Acute Paediatric Emergencies & Critical Care
EPLS/PALS Structured Approach, Types of Shock, and Weight-Based Fluid Boluses Clinical Diagnostic Criteria, Intramuscular Adrenaline Dosing, and Refractory Anaphylaxis 5-Minute Time-Critical Anticonvulsant Protocol and Status Epilepticus Care Common Toxidromes (Paracetamol, Iron, Caustics, Button Batteries) and Decontamination
5 Chapter 5: Paediatric Respiratory Medicine
Stridor Differential, Croup (Westley Score & Dexamethasone), and Epiglottitis RSV Pathogenesis, Supportive Management, Oxygen/High-Flow Criteria, and Futility of Bronchodilators/Steroids European/BTS Guidelines on Chronic Stepwise Control and Acute Severe Exacerbation Management Community-Acquired Pneumonia Etiology, Parapneumonic Effusion/Empyema, and Cystic Fibrosis Pulmonary Exacerbations
6 Chapter 6: Paediatric Cardiology
Acyanotic vs Cyanotic Congenital Heart Disease: Ductal Patency, Shunt Lesions, and Emergency Stabilization Paediatric Murmurs and Arrhythmias: Innocent vs Pathological Murmurs, SVT, and Resuscitation Protocols Acquired Heart Disease: Kawasaki Disease, Coronary Aneurysm Prevention, and Acute Rheumatic Fever
7 Chapter 7: Paediatric Gastroenterology, Hepatology & Nutrition
Dehydration Severity Assessment, Oral Rehydration Therapy (ORT), and Intravenous Fluid Protocols ESPGHAN Coeliac Diagnostic Criteria (Biopsy-Sparing Pathway) and Paediatric Crohn's/Ulcerative Colitis Breastfeeding, Formula Selection, Cow's Milk Protein Allergy (CMPA), GERD vs GOR, and Faltering Growth Prolonged Neonatal Jaundice Workup, Biliary Atresia Red Flags, and Acute Hepatitis/Liver Failure
8 Chapter 8: Paediatric Nephrology, Fluids & Electrolyte Balance
Paediatric UTI Diagnosis, Imaging Criteria (Ultrasound/DMSA/MCUG), and Vesicoureteral Reflux Minimal Change Nephrotic Syndrome (Steroid Regimen & Complications) vs Acute Post-Infectious Glomerulonephritis Paediatric AKI (pRIFLE/KDIGO), Haemolytic Uraemic Syndrome (HUS), and Hyperkalaemia/Dysnatraemia Management
9 Chapter 9: Paediatric Endocrinology & Inborn Errors of Metabolism
Paediatric DKA Protocol (ISPAD/European Fluid & Insulin Guidelines, Cerebral Oedema Prevention) and T1DM Maintenance Congenital Hypothyroidism Screening & Levothyroxine, Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency), and Adrenal Crisis Short Stature Workup, Precocious vs Delayed Puberty, and Approach to Suspected Inborn Errors of Metabolism (IEM)
10 Chapter 10: Paediatric Neurology, Neurodevelopment & Mental Health
Simple vs Complex Febrile Seizures, Childhood Epilepsy Syndromes (Absence, Infantile Spasms, Benign Rolandic), and Antiseizure Medications Red Flags for Raised Intracranial Pressure (ICP), Brain Tumours, Migraine vs Tension Headache Acute Bacterial Meningitis (LP Contraindications, Ceftriaxone, Dexamethasone) and Viral Encephalitis (Aciclovir) Developmental Milestones (Gross Motor, Fine Motor/Vision, Speech/Language, Social), Autism Spectrum, ADHD, and Cerebral Palsy
11 Chapter 11: Paediatric Haematology & Oncology
Microcytic Anaemia (Iron Deficiency vs Thalassaemia Trait/Mentzer Index), Haemolytic Anaemias (Spherocytosis, G6PD) Sickle Cell Crises (Vaso-occlusive, Acute Chest Syndrome, Stroke Prevention), Immune Thrombocytopenia (ITP), and Haemophilia A/B Acute Lymphoblastic Leukaemia (ALL), Neuroblastoma, Wilms Tumour, and Management of Febrile Neutropenia
12 Chapter 12: Paediatric Infectious Diseases, Immunology & Allergy
Common Childhood Exanthems: Clinical Morphology, Timelines, Complications, and Management Paediatric Tuberculosis, Sepsis Six in Children, and Acute Osteoarticular Infections Pediatric Allergy, Atopic Eczema, Food Hypersensitivity, and Desensitization Primary Immunodeficiencies, Warning Signs, Live Vaccine Contraindications, and European Immunisation Schedules
13 Chapter 13: Paediatric Musculoskeletal, Dermatology & Surgical Conditions
The Limping Child, Septic Arthritis vs Transient Synovitis, and Juvenile Idiopathic Arthritis Henoch-Schönlein Purpura, Kawasaki Disease vs MIS-C, Infantile Haemangiomas, and Common Pediatric Eruptions Acute Appendicitis, Intussusception, Pyloric Stenosis, Testicular Torsion, and Incarcerated Hernia
14 Chapter 14: Research Methods, Biostatistics & Evidence-Based Paediatrics
Study Designs, Causality, Bias, and Epidemiological Measures in Paediatrics Diagnostic Test Accuracy, Statistical Inference, and Hypothesis Testing Systematic Reviews, Meta-Analysis, Decision Analysis, and Paediatric Research Ethics
15 Chapter 15: Paediatric Ophthalmology & ENT Disorders
Paediatric Vision Assessment, Refractive Disorders, Strabismus, and Leukocoria Ocular Emergencies, Orbital Infections, ROP, and Systemic Manifestations Paediatric Otolaryngology: Otitis Media, Hearing Impairment, and Upper Airway Conditions
16 Chapter 16: Paediatric Sports Medicine & Musculoskeletal Health
Skeletal Maturity, Physeal Injuries, Apophysitis, and Overuse Syndromes Paediatric Sports Concussion, Second Impact Syndrome, and Return-to-Play Protocols Pre-Participation Screening, Physical Activity Guidelines, and Chronic Disease Clearance
17 Chapter 17: Adolescent Medicine & Healthcare Transition
Biopsychosocial Development, Pubertal Staging, and Adolescent Communication Adolescent Confidentiality, Risk Behaviours, Reproductive Health, and Eating Disorders Chronic Illness in Adolescence and Structured Healthcare Transition
18 Chapter 18: Paediatric Genetics, Dysmorphology & Clinical Genomics
Patterns of Inheritance, Non-Mendelian Mechanisms, and Pedigree Construction Clinical Dysmorphology, Chromosomal Aneuploidies, and Microdeletion Syndromes Genetic Testing Technologies, Prenatal Diagnosis, and Genetic Counselling Ethics
19 Chapter 19: Paediatric Mental Health, Behaviour & Community Medicine
Cognitive Development, Attachment, Screening, and Common Emotional Disorders Regulatory Disorders, Neurodevelopmental Behavioural Conditions, and Psychosomatic Illness Community Child Healthcare Structures, Disability Coordination, and Child Advocacy
Paediatric Ethics, Consent/Assent, Gillick Competence, and Patient Safety
Key Takeaways Explain This Topic AI
Article 3 of the UN Convention on the Rights of the Child makes the child’s best interests a primary consideration; serious disagreement over treatment requires appropriate safeguarding and legal procedures.
In England and Wales, an under-16 may consent if Gillick competent. Rules on consent and refusal vary by jurisdiction; a competent refusal of life-sustaining treatment needs urgent specialist and legal review.
Emergency life-saving medical treatment must never be delayed to resolve parental disagreements, obtain judicial declarations, or address religious objections when a child faces imminent death or irreversible physiological deterioration.
Paediatric medication safety uses current kilogram weights, clear units and dosing, standardised preparations, appropriate independent checks and a reporting culture that learns from error.
Last updated: November 2026
Paediatric Bioethics, Consent, Governance, and Patient Safety
Paediatric practice operates under a unique ethical and legal paradigm distinct from adult medicine. Whereas adult clinical ethics centers predominantly on individual patient autonomy, paediatric medicine functions within a triadic relationship encompassing the child patient, the parents or legal guardians, and the healthcare team. Navigating this dynamic requires balancing parental responsibility against the child's evolving autonomy, adhering to child rights frameworks, and maintaining uncompromising standards of clinical safety.
Core Bioethical Principles in Paediatrics
Modern paediatric ethics integrates the traditional four principles of biomedical ethics (Beauchamp and Childress) through the lens of developmental physiology and international law:
Best Interests of the Child : Codified in Article 3 of the United Nations Convention on the Rights of the Child (UNCRC) , the child’s best interests must be a primary consideration. When parental refusal risks serious harm, seek safeguarding and legal support; provide immediately necessary treatment in an emergency.
Beneficence : The physician's positive obligation to act in the physical, emotional, and developmental benefit of the infant, child, or young person.
Non-Maleficence : The duty to protect children from avoidable physical suffering, procedural trauma, and excessive or futile medical intervention.
Respect for Evolving Autonomy : In accordance with Article 12 of the UNCRC , children who are capable of forming their own views have the right to express those views freely in all matters affecting them, with the views being given due weight in accordance with their age and maturity.
Parental Responsibility versus Parental Disputes
Consent law differs across Europe. The following examples use England and Wales , where parental responsibility concerns duties and powers in relation to a child. Check the applicable national law before applying these rules elsewhere.
Scope of Parental Responsibility
Routine Care : For everyday medical interventions (e.g., standard physical examinations, routine childhood immunizations, prescribing standard oral antibiotics for acute otitis media), the consent of one individual holding parental responsibility is legally and clinically sufficient.
Disputes Between Parents : When two parents with parental responsibility disagree on a non-emergency, irreversible, or contentious procedure (e.g., elective non-therapeutic circumcision, gender-affirming interventions, long-term experimental therapies, or disputes over routine MMR immunization during marital separation), the clinician must not act unilaterally . Seek senior and legal advice, try to resolve the disagreement and obtain court guidance where necessary; do not delay emergency care.
Parental Refusal of Life-Saving Treatment : When parents refuse life-sustaining therapy on philosophical, religious, or personal grounds (e.g., Jehovah's Witness parents refusing life-saving blood transfusion for an infant in hemorrhagic shock), the clinical team must never allow the child to die or suffer catastrophic harm . Under the emergency doctrine of necessity, life-saving resuscitation must proceed immediately, with hospital legal services and judicial guardianship authorities engaged in parallel.
Warning
In an acute, life-threatening emergency, obtaining consent from parents or awaiting a court declaration must never delay immediate resuscitation . In England and Wales, immediately necessary treatment may be given without parental consent to save a child’s life or prevent serious deterioration; seek senior and legal help alongside resuscitation.
Consent, Assent, and Gillick Competence
Paediatric practice recognizes a continuum of decision-making that shifts from pure parental proxy consent in infancy to autonomous adolescent decision-making.
Developmental Stage Decision-Making Capacity Ethical and Legal Mechanism Clinical Application
Infant / Young Child Understanding depends on development and the decision Parental Consent When the Child Lacks Capacity Explain simply, involve the child and assess best interests
Child Developing Understanding Can participate even without capacity for the decision Paediatric Assent Explain, seek agreement and take distress or dissent seriously
Young Person Under 16: England and Wales Assess maturity and understanding for the specific treatment Gillick Competence A competent young person may consent; age alone does not decide capacity
Young Person Aged 16–17: England and Wales Capacity to consent is presumed Consent and Confidentiality Involve parents with the young person’s agreement; legal and safeguarding exceptions still apply
Paediatric Assent
Assent is the affirmative agreement of a child to participate in medical care or research when they lack the legal capacity to give fully binding informed consent. Achieving assent involves:
Educating the child about the nature of the condition using age-appropriate terminology and visual aids.
Explaining what the child can expect during procedures (e.g., sensations, duration).
Assessing the child's understanding and inviting questions.
Seeking the child's explicit, voluntary agreement to proceed.
While a child's dissent should be honored for non-essential or elective procedures, assent cannot override parental consent when an intervention is life-saving or medically mandatory.
The Gillick Competency Standard
In England and Wales, following Gillick v West Norfolk and Wisbech Area Health Authority (1985) , Gillick competence establishes that a minor under the age of 16 years has the legal capacity to consent to medical treatment if they demonstrate sufficient intelligence, maturity, and understanding to fully comprehend what is proposed.
To establish Gillick competence, the clinician must confirm that the adolescent can:
- Comprehend the nature, purpose, and clinical justification for the proposed treatment
- Understand the potential risks, side effects, complications, and alternative management options
- Understand the consequences of refusing the intervention
Retain the information, weigh the competing clinical arguments, and communicate a reasoned decision free from parental or peer coercion
The Fraser Guidelines
The Fraser guidelines concern confidential contraceptive advice and treatment for under-16s in the UK. The following five criteria apply to contraception; abortion and STI care require the relevant legal and professional guidance, including GMC guidance on confidential care.
The young person understands the clinician's advice and medical implications.
The clinician cannot persuade the young person to inform their parents or to allow the clinician to inform them.
The young person is very likely to begin or continue having sexual intercourse with or without contraceptive treatment.
Unless the young person receives contraceptive advice or treatment, their physical or mental health (or both) is likely to suffer.
The young person's best interests require the clinician to give contraceptive advice, treatment, or both without parental consent.
The Asymmetry of Gillick Competence: Consent versus Refusal
Consent and refusal require distinct legal assessment:
Consent in England and Wales : Parents cannot override a competent young person’s consent to treatment that the clinician considers in their best interests.
Refusal : Take a competent refusal seriously and assess capacity, the proposed treatment’s benefits and burdens, and the young person’s views. In England and Wales, the High Court may authorise treatment despite refusal; seek urgent legal advice rather than assuming parental consent resolves it.
Jurisdiction : In Scotland, parents cannot authorise treatment a competent young person has refused. Apply the relevant national law, involving senior clinicians, an advocate and legal advisers where needed.
Withholding and Withdrawing Life-Sustaining Treatment (WLST)
End-of-life decisions in neonatal and paediatric intensive care represent some of the most profound challenges in medicine. Guided by frameworks from the European Academy of Paediatrics (EAP) and the Royal College of Paediatrics and Child Health (RCPCH), withholding or withdrawing life-sustaining treatment (WLST) is ethically and legally justified when continuing technological intervention fails to provide overall benefit to the child.
Clinical Situations Where WLST May Be Considered
Brain Death : Formal confirmation of death by neurological criteria (brainstem death).
The Imminent Death Group : Technological support merely delays inevitable physiological death by hours or days without altering the ultimate outcome.
The Inevitable Death Group : Progressive, incurable conditions where intensive therapy could prolong life for weeks or months, but only at the cost of severe, unmanageable suffering.
The No Purpose Group : The child may survive for an extended period, but the degree of permanent neurological impairment is so profound that the child has no awareness of self or environment and no capacity for relational engagement.
The Unbearable Burden Group : The burden of ongoing intensive treatment (e.g., recurrent invasive interventions, intractable pain) vastly outweighs any potential developmental or quality-of-life gains.
Conflict Resolution Framework
When discord arises between the multidisciplinary team and the family regarding WLST:
Arrange structured, empathetic case conferences with continuous involvement of pediatric palliative care specialists and spiritual/cultural support.
Solicit an independent second medical opinion from an external tertiary specialist.
Refer the case to the hospital's Clinical Ethics Committee (CEC) for formal multidisciplinary deliberation.
If irreconcilable differences persist, apply to the relevant high court or judicial tribunal for an independent legal determination based on the child's best interests.
Patient Safety and Paediatric Medication Errors
Children are at significantly higher risk of medication-related adverse events than adults due to unique developmental factors:
Weight-Based Dosing : Almost all pediatric drug dosing is calculated based on body weight (mg/kg) or body surface area (BSA, mg / m 2 \text{mg}/\text{m}^2 mg / m 2 ). Mathematical miscalculations frequently generate tenfold (10×) or hundredfold (100×) overdoses .
Physiological Immaturity : Neonates and infants have immature renal tubular secretion, reduced glomerular filtration, and immature hepatic cytochrome P450 enzyme systems, dramatically slowing drug clearance.
Lack of Pediatric Formulations : Adult dosage forms must often be diluted or manipulated into extemporaneous liquid suspensions, multiplying the opportunities for compounding and administration errors.
Error Type High-Risk Pediatric Mechanism Preventative Safety Defense
Tenfold Decimal Error Trailing zeros (e.g., writing "5.0 mg" misread as 50 mg) or missing leading zeros (".5 mg" read as 5 mg) Strict ban on trailing zeros; mandatory leading zeros ("0.5 mg"); computerized prescriber order entry (CPOE)
Unit Confusion Mixing milligrams (mg) and micrograms (mcg or μ g \mu\text{g} μ g ) Standardized dosing units; write "micrograms" in full; electronic forcing functions
Weight Discrepancy Using outdated historical weights or pounds instead of kilograms Mandatory weigh-in on admission in kilograms; hard-stop digital weight checks
Dilution Calculation Concentrated neonatal infusions (e.g., morphine, insulin) Standardized “smart pumps” with integrated drug libraries and dose error reduction systems (DERS)
Tip
Use genuinely independent checks for selected high-risk medicines according to local policy, alongside standard concentrations, prescribing support and infusion safeguards. The second practitioner checks the order, calculation and prepared medicine separately; a double-check is one safety layer, not a substitute for a reliable medication system.
Developmental Pharmacology and Rational Prescribing
Children are not small adults: absorption, distribution, metabolism and excretion all change with age, so the same mg/kg dose can produce very different drug exposure.
Process Neonates and young infants Practical consequence
Absorption Higher gastric pH, variable gastric emptying, thin skin with a large surface area for body weight Oral bioavailability varies; topical drugs and antiseptics can cause systemic toxicity
Distribution Larger proportion of body water; lower plasma protein binding Water-soluble drugs such as gentamicin need larger mg/kg doses; drugs that displace bilirubin from albumin (for example ceftriaxone or sulfonamides) are avoided in jaundiced neonates
Metabolism Immature cytochrome P450 and glucuronidation pathways that mature over the first months Slow clearance of some drugs (chloramphenicol caused grey baby syndrome); young children may later clear some drugs faster per kg than adults
Excretion Low glomerular filtration rate that reaches adult values, corrected for body surface area, by about 1–2 years Longer dosing intervals and drug-level monitoring for renally cleared drugs such as gentamicin and vancomycin
Pregnancy and Breastfeeding
Small, lipid-soluble, unionised and poorly protein-bound drugs cross the placenta most readily. Structural teratogenic risk is greatest during organogenesis in the first trimester, while drugs given near delivery can affect the newborn (for example opioid respiratory depression or withdrawal).
Most maternal medicines are compatible with breastfeeding. Check a lactation reference such as LactMed. Codeine should not be used by breastfeeding mothers because morphine can reach toxic levels in the infant.
Licensing, Formularies and Drug Choice
Many paediatric prescriptions are off-label (outside the licensed age, indication, dose or route) or unlicensed (for example extemporaneous liquids), especially in neonates. This is lawful and often necessary when supported by evidence: use a paediatric formulary or guideline, explain this to parents and document it. The EU Paediatric Regulation (EC) No 1901/2006 requires paediatric investigation plans for new medicines.
Prescribe from a current weight in kilograms, calculate the mg/kg dose, and do not exceed the adult maximum dose.
Choose a formulation, taste, volume and dosing frequency the child can manage, because adherence depends on them. Generic medicines are bioequivalent and usually cheaper; for a few antiseizure medicines such as carbamazepine and phenytoin, keep the child on the same manufacturer's product.
Pain Management
Assess pain with age-appropriate validated tools: behavioural scales such as FLACC in preverbal children, a faces scale in young children and a numerical scale in older children.
Combine non-drug measures (comfort, distraction, breastfeeding or oral sucrose for minor procedures in neonates) with analgesia: paracetamol and/or ibuprofen for mild to moderate pain, an opioid such as morphine with monitoring for severe pain, and topical anaesthetic before cannulation.
Codeine should not be used for pain in children under 12 years and is contraindicated in anyone under 18 years after tonsillectomy or adenoidectomy for obstructive sleep apnoea.
Iatrogenic Drug Withdrawal
Consider withdrawal after about 5 days or more of continuous opioid or benzodiazepine infusion, for example in paediatric intensive care. Abrupt cessation can cause irritability, tremor, sweating, fever, tachycardia, vomiting, diarrhoea and poor sleep. Assess with a validated scale such as the WAT-1 or SOS, exclude pain and delirium, and wean gradually.
Sources: EMA Paediatric Regulation ; MHRA codeine restrictions in children ; MHRA antiepileptic product switching ; ESPNIC pain, sedation and withdrawal assessment .
Complementary and Alternative Treatments in the Medication History
Ask families about supplements, herbal products and traditional or complementary practices. Children with chronic conditions may use these alongside conventional care; ask about their purpose and expected benefit. Review the exact product, ingredients and dose alongside prescribed medicines. Paediatric efficacy and safety evidence is limited for many approaches; natural products may cause adverse effects, interact with medicines or contain contaminants. Assess each proposed treatment on its own evidence and risks. Discuss use without dismissing the family, coordinate care, and explain that unproven products should not replace or delay effective assessment or prescribed treatment.
Source: NCCIH guidance on complementary approaches in children .
Open Disclosure and Clinical Incident Reporting
When a medical error or patient safety incident occurs, healthcare organizations must respond through a structured, transparent governance framework.
Professional Candour and Provider Duties
Clinicians have a professional duty to be open and honest when care goes wrong. Statutory duties vary by jurisdiction: in England, Regulation 20 sets additional requirements for regulated providers when a notifiable safety incident meets the relevant harm threshold. Professional disclosure should include:
Prompt Communication : Inform the child's parents or legal guardians as soon as reasonably practicable after the incident.
Truthful Narrative : Provide a clear, factual explanation of what occurred, what is currently known, and what further investigations are underway.
Sincere Apology : Offer a meaningful expression of sorrow and regret. CQC guidance emphasises that saying sorry does not mean admitting fault.
Remediation : Detail the immediate clinical steps taken to mitigate harm and outline systemic improvements instituted to prevent recurrence.
The "Just Culture" Model
Modern clinical governance distinguishes between three classes of human behavior (Reason's Just Culture framework):
Human Error : Inadvertent slips, lapses, or mistakes (e.g., selecting the wrong dropdown item in an unfamiliar electronic interface). Response: Consolation, system redesign, and training.
At-Risk Behavior : Behavioral choice where risk is not recognized or is mistakenly considered justified (e.g., taking a shortcut by bypassing an independent double-check to speed up antibiotic delivery). Response: Coaching, removing behavioral incentives for shortcuts, and reinforcing safety barriers.
Reckless Conduct : Conscious disregard of a substantial and unjustifiable risk (e.g., administering an intravenous drug while intoxicated). Response: Remedial disciplinary or regulatory action.
Professional Practice: Communication, Teamwork, Quality and Lifelong Learning
The Common Trunk's general goals cover the non-technical skills that make clinical knowledge safe. Exam vignettes test them as the safest next professional action.
Communicating with Children and Families
Build an age-appropriate therapeutic relationship : greet and speak to the child directly at their developmental level, and offer adolescents time alone.
Elicit the child's and family's concerns, expectations, values, culture and religion. When language differs, use a professional interpreter , not a sibling, the child or another relative.
Breaking bad news or crisis communication (for example the SPIKES steps: setting, perception, invitation, knowledge, emotions, strategy and summary): use a private room, involve both parents where possible, find out what they already understand, give information in small jargon-free pieces, pause for emotion, and agree the next steps and follow-up.
Develop a shared care plan with the family and other professionals, and convey it in clear oral and written communication such as clinic letters and discharge summaries.
Teamwork, Handover, Prioritisation and Escalation
Use a structured handover (for example SBAR or ISBAR: identify, situation, background, assessment, recommendation) at shift change, referral and transfer. Include pending results, outstanding tasks and the escalation plan.
Value the contribution of nurses, allied health professionals and other colleagues, and encourage every team member to speak up about safety.
Prioritise by clinical urgency, delegate to competent colleagues with clear instructions, follow tasks up, and ask for senior help early . Knowing your limits is a professional duty.
Start discharge planning on admission: criteria for discharge, medicines and their administration, safety-netting advice and follow-up.
Records, Probity and Public-Health Duties
Keep records contemporaneous, legible, dated, timed and signed , with the author identifiable. Corrections must remain visible. Record findings, reasoning, decisions and what was discussed with the family.
Be honest, reliable and accessible to patients and colleagues, and treat every child fairly regardless of gender, age, culture, ethnicity, religion or disability.
Report notifiable infectious diseases to public-health authorities as national law requires.
Quality Improvement and Patient Safety
Clinical audit cycle : agree a standard, measure current practice, compare with the standard, implement change and re-audit.
Plan–Do–Study–Act (PDSA) cycles test small changes quickly and use measurement over time to see whether care improves.
Report incidents and near misses so that the system can learn.
Lifelong Learning, Teaching and Wellbeing
Keep a personal development plan and reflect on practice, feedback and incidents.
Answer clinical questions with a focused PICO question, a structured search of databases such as MEDLINE/PubMed and the Cochrane Library, and critical appraisal of what is found.
Teach and supervise students and junior colleagues, give specific and constructive feedback, and use mentoring and educational supervision.
Look after your own and your team's health. Fatigue, stress and burnout impair performance; seek support early and do not work when unfit to practise.
Sources: WHO Patient Safety Curriculum Guide: Multi-professional Edition ; GMC Good medical practice ; SPIKES protocol for delivering bad news .